This federal contract award, with identification number SPE2DB22D3301|SPE2DB25FX7VK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $12,428.72, is for the delivery of OGIVRI 420 MG vials, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical program. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 9:46 AM